Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Rowers' back pain breakthrough: lighter training with BFR may be just as effective

NCT ID NCT07130812

Symptom relief Sponsor: Loma Linda University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether low-load blood flow restriction training (LL-BFR) can help young rowers with mild or recurring low back pain. Researchers want to see if this gentler method is as good as heavy lifting for building strength and preventing re-injury. About 120 rowers aged 13-20 will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

13 to 20 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 13-20 years old * Currently active rower (training ≥3 days/week or 12 hours/week) * Mild LBP with a low reactivity (\<3/10) or recurring LBP within the past 18 months that has affected attendance to team practices/races. * Able to complete a 2,000-meter rowing erg test Exclusion Criteria: * Have severe or acute back pain that limits basic movement or requires medical treatment * History of spinal surgery or structural spine conditions (scoliosis requiring bracing/surgery) * Have a contraindication to BFR training, identified via BFR safety screening form: * Peripheral vascular disease (PVD) * History of vascular surgery in arms or legs * Skin grafts on arms or legs * Arteriovenous fistula in limbs * Cognitive or physical impairment that limits participation * Hypertension or high blood pressure (uncontrolled or undiagnosed) * Bleeding disorders (e.g., hemophilia) * Blood clotting disorders (e.g., lupus, factor-V Leiden) * Past history of DVT or pulmonary embolism (PE) * Surgery in the past 12 weeks * Recent limb immobilization (e.g., cast, boot) in the last 4 weeks * History of stroke or transient ischemic attack (TIA) * History of cancer * Diagnosed heart disease * History of rhabdomyolysis * Diagnosed diabetes * Sickle cell disease * History of compartment syndrome * History of nerve damage or injury * Any prior complications or adverse reactions to BFR training * Any other medical conditions that should be cleared by a physician before starting BFR * Pregnancy(Self-reported)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Low back pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Low back pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Loma Linda University

    RECRUITING

    Loma Linda, California, 92350, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.